Database of Interstitial Lung Diseases
This trial is active, not recruiting.
|Condition||interstitial lung diseases|
|Sponsor||St. Antonius Hospital|
|Start date||January 2006|
|Trial size||100000 participants|
|Trial identifier||NCT00267800, R05.08/A|
The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Nieuwegein, Netherlands||St. Antonius Hospital||no longer recruiting|
|Utrecht, Netherlands||UMC Utrecht||no longer recruiting|
|Utrecht, Netherlands||Mesos Medisch Centrum||no longer recruiting|
|Utrecht, Netherlands||Diakonessenhuis||no longer recruiting|
Male or female participants at least 18 years old.
Inclusion Criteria: - Diagnosis of an ILD, as stated by the American Thoracic Society (ATS)
|Official title||Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)|
|Principal investigator||J.M.M. van den Bosch, M.D.|
|Description||Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs. Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research. Study design: A prospective observational study Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals. Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file. Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies. Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.|
Call for more information